Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 29, 1997

View Archived Issues

Company Profile: Sugen

SS Pharm. patents new antifungal agents

New antiallergic agents from Dainippon Ink & Chemicals

Otsuka's new antidiabetic agents

FDA clears new oral treatment for hair loss in men

TOBI approved by FDA for management of CF patients

FDA approval obtained for Prandin

Teveten cleared for U.S. marketing

SAR leading to new topoisomerase I inhibitor presented by Banyu

Suntory in-licenses new antidementia agent

VRCTC-310: MTD, preliminary efficacy and pharmacokinetic data in humans

DX-9065a exhibits antithrombotic efficacy and no effects on hemostasis in animal model

Phase IIb trial of TCR vaccine for rheumatoid arthritis begins

Alferon evaluated in patients coinfected with HIV and HCV

MedImmune and BioTransplant plan to test MEDI-507 for graft-vs.-host disease

Alexion files IND for C5 inhibitor treatment for rheumatoid arthritis

NDA filed for extended-release Ditropan formulation

Triangle Pharmaceuticals plans to reinitiate trials with DMP-450

Lidak submits NDA for Lidakol

Aronex/Ferrer seek approval of Nyotran in Spain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...